170 related articles for article (PubMed ID: 14733414)
1. Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis.
Montero A; Uda S; Kelavkar U; Yoshimura A; Badr KF; Munger KA
J Nephrol; 2003; 16(5):682-90. PubMed ID: 14733414
[TBL] [Abstract][Full Text] [Related]
2. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
3. Expression of 5-lipoxygenase and 5-lipoxygenase activation protein in glomerulonephritis.
Rifai A; Sakai H; Yagame M
Kidney Int Suppl; 1993 Jan; 39():S95-9. PubMed ID: 8468935
[TBL] [Abstract][Full Text] [Related]
4. Distinct parts of leukotriene C(4) synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein.
Strid T; Svartz J; Franck N; Hallin E; Ingelsson B; Söderström M; Hammarström S
Biochem Biophys Res Commun; 2009 Apr; 381(4):518-22. PubMed ID: 19233132
[TBL] [Abstract][Full Text] [Related]
5. Hyperoxia increases protein mass of 5-lipoxygenase and its activating protein, flap, and leukotriene B(4) output in newborn rat lungs.
Hosford GE; Koyanagi KS; Leung WI; Olson DM
Exp Lung Res; 2002 Dec; 28(8):671-84. PubMed ID: 12490039
[TBL] [Abstract][Full Text] [Related]
6. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils.
Cowburn AS; Holgate ST; Sampson AP
J Immunol; 1999 Jul; 163(1):456-65. PubMed ID: 10384149
[TBL] [Abstract][Full Text] [Related]
7. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats.
Valdivielso JM; Montero A; Badr KF; Munger KA
J Nephrol; 2003; 16(1):85-94. PubMed ID: 12649539
[TBL] [Abstract][Full Text] [Related]
9. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.
Woods JW; Evans JF; Ethier D; Scott S; Vickers PJ; Hearn L; Heibein JA; Charleson S; Singer II
J Exp Med; 1993 Dec; 178(6):1935-46. PubMed ID: 8245774
[TBL] [Abstract][Full Text] [Related]
10. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis.
Nishikawa K; Andres G; Bhan AK; McCluskey RT; Collins AB; Stow JL; Stamenkovic I
Lab Invest; 1993 Feb; 68(2):146-53. PubMed ID: 7680079
[TBL] [Abstract][Full Text] [Related]
13. Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis.
Katoh T; Lakkis FG; Makita N; Badr KF
Kidney Int; 1994 Aug; 46(2):341-9. PubMed ID: 7967345
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effect of arachidonate 5-lipoxygenation on glomerular cell proliferation in nephrotoxic serum nephritis.
Wu SH; Lianos EA
J Lab Clin Med; 1993 Dec; 122(6):703-10. PubMed ID: 8245690
[TBL] [Abstract][Full Text] [Related]
15. Changes of 5-lipoxygenase pathway and proinflammatory mediators in cerebral cortex and lung tissue of sensitized rats.
Deng YM; Xie QM; Zhang SJ; Chen JQ; Yang QH; Bian RL
Acta Pharmacol Sin; 2005 Mar; 26(3):353-8. PubMed ID: 15715933
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
Voelkel NF; Tuder RM; Wade K; Höper M; Lepley RA; Goulet JL; Koller BH; Fitzpatrick F
J Clin Invest; 1996 Jun; 97(11):2491-8. PubMed ID: 8647941
[TBL] [Abstract][Full Text] [Related]
17. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.
Zhao L; Moos MP; Gräbner R; Pédrono F; Fan J; Kaiser B; John N; Schmidt S; Spanbroek R; Lötzer K; Huang L; Cui J; Rader DJ; Evans JF; Habenicht AJ; Funk CD
Nat Med; 2004 Sep; 10(9):966-73. PubMed ID: 15322539
[TBL] [Abstract][Full Text] [Related]
18. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.
Wright L; Tuder RM; Wang J; Cool CD; Lepley RA; Voelkel NF
Am J Respir Crit Care Med; 1998 Jan; 157(1):219-29. PubMed ID: 9445303
[TBL] [Abstract][Full Text] [Related]
19. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
20. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.
Dixon RA; Diehl RE; Opas E; Rands E; Vickers PJ; Evans JF; Gillard JW; Miller DK
Nature; 1990 Jan; 343(6255):282-4. PubMed ID: 2300173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
